What is the appropriate dose conversion from telmisartan to irbesartan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Telmisartan to Irbesartan Conversion

When converting from telmisartan to irbesartan, use a 1:3.75 ratio: telmisartan 40 mg converts to irbesartan 150 mg, and telmisartan 80 mg converts to irbesartan 300 mg.

Dose Equivalency

The FDA-approved dosing ranges provide the framework for conversion 1:

  • Telmisartan: 20-80 mg once daily (usual starting dose 40 mg)
  • Irbesartan: 150-300 mg once daily

Based on the standard therapeutic doses used in clinical practice and research:

  • Telmisartan 40 mg → Irbesartan 150 mg
  • Telmisartan 80 mg → Irbesartan 300 mg

This conversion ratio is consistently supported across multiple comparative studies 2, 3, 4, 5 where telmisartan 40-80 mg was directly compared with irbesartan 150-300 mg as equipotent antihypertensive doses.

Clinical Considerations

Blood pressure monitoring is essential after conversion 1. The antihypertensive effect reaches maximum reduction after 4 weeks with telmisartan, so reassess blood pressure at 2-4 weeks post-conversion.

Important Differences Between These ARBs

While both are effective antihypertensives, telmisartan demonstrates superior metabolic effects:

  • Telmisartan acts as a partial PPARγ agonist, while irbesartan has minimal PPARγ activity 3, 4, 5
  • In diabetic patients, telmisartan produces greater improvements in insulin resistance (HOMA-IR decreased 29% vs increased 16% with irbesartan) 2
  • Telmisartan increases adiponectin more effectively via PPARα activation 6

A recent 2024 network meta-analysis found telmisartan and olmesartan demonstrated the best balance of efficacy and safety among ARBs 7, suggesting you may want to reconsider whether switching away from telmisartan is necessary.

Practical Switching Protocol

  1. Stop telmisartan and start irbesartan the next day (no washout needed)
  2. Use the conversion ratios above based on current telmisartan dose
  3. Monitor blood pressure at 2 weeks and 4 weeks post-conversion
  4. Titrate irbesartan to 300 mg if blood pressure control is inadequate at 150 mg

Special Populations

  • No dose adjustment needed for elderly patients or those with renal impairment, including hemodialysis 1
  • Monitor closely for orthostatic hypotension in dialysis patients
  • Both drugs are contraindicated in pregnancy 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.